Hosted on MSN1mon
Gyre therapeutics president Ma Songjiang sells $46,360 in stockSAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback